https://pmc.ncbi.nlm.nih.gov/articles/PMC11897627/
Risk factors for immunoresistance in advanced non-small cell lung cancer and the advantages of...
Objectives: The advent of immunotherapy has transformed the therapeutic landscape for advanced non-small cell lung cancer (NSCLC); nonetheless, the emergence...